Stories indexed under: Stem cells

Total: 149   RSS feed

• Wisconsin stem cell pioneer wins Faisal International Prize Jan. 21, 2011 James Thomson, director of regenerative biology at the Morgridge Institute for Research and a University of Wisconsin-Madison researcher since 1994, learned this week that he is this year's co-winner of the prestigious King Faisal International Prize in Medicine.
• Embryonic stem cell culturing grows from art to science Nov. 14, 2010 Growing human embryonic stem cells in the lab is no small feat. Culturing the finicky, shape-shifting cells is labor intensive and, in some ways, more art than exact science.
• Court puts stem cell researchers back to work, for now Sept. 9, 2010 A panel of appellate judges removed barriers to embryonic stem cell research funded by federal grants in a decision Thursday, Sept. 9 reversing a suspension of funding ordered in August by another federal judge.
• Gene regulating human brain development identified July 1, 2010 With more than 100 billion neurons and billions of other specialized cells, the human brain is a marvel of nature. It is the organ that makes people unique.
• NIH reapproves WiCell’s H9 and three other Wisconsin stem cell lines for federally funded research April 27, 2010 Today the National Institutes of Health reapproved the WiCell Research Institute's H9 (WA09) human embryonic stem (ES) cell line, the most used and cited in scientific research, for ongoing use in federally funded research.
• Stem cell symposium to focus on hurdles in stem cell therapy development April 15, 2010 The fifth annual Wisconsin Stem Cell Symposium, called "The Road to Stem Cell Applications: Bioprocessing, Safety and Preclinical Evaluation," will be held on Wednesday, April 21 just outside of Madison.
• WiCell marks stem cell anniversary with WISC Bank expansion March 9, 2010 A year after President Barack Obama issued a landmark executive order to remove eight years of limitations on U.S. federal funding of stem cell research, the WiCell Research Institute has expanded the number of cell lines available through its WISC Bank to 33.
• Induced neural stem cells: Not quite ready for prime time Feb. 15, 2010 The great promise of induced pluripotent stem cells is that the all-purpose cells seem capable of performing all the same tricks as embryonic stem cells, but without the controversy.
• Morgridge Institute for Research announces scientific leadership team, research areas Feb. 10, 2010 The Morgridge Institute for Research has finalized its inaugural team of top scientists selected to bring to life the institute's mission of accelerating discovery to delivery to improve human health.
• Stem cells: Science, economy edge religion at the polls Feb. 3, 2010 When it comes to stem cell research as a political issue, Wisconsin voters are more likely to be motivated by ideas of economic benefit and scientific progress than by religious objections, according to a new report.
• NIH approves Wisconsin H1 stem-cell line for continued use in federally funded research Jan. 29, 2010 The WiCell Research Institute can continue to provide stem cell scientists one of the earliest and most popular human embryonic stem cell (hESC) lines in the field for their use in federally funded research projects.
• Federal grant funds production of stem cells for clinical trials Jan. 26, 2010 The long struggle to move the most versatile stem cells from the laboratory to the clinic got another boost with an $8.8 million contract award to the Waisman Clinical Biomanufacturing Facility at the University of Wisconsin-Madison.
• UW-Madison heart stem cell study among top research advances Jan. 22, 2010
• Regulatory network balances stem cell maintenance, differentiation Jan. 11, 2010 While much of the promise of stem cells springs from their ability to develop into any cell type in the body, the biological workings that control that maturation process are still largely unknown.
• WiCell donates $1 million in gear to UW-Madison labs Sept. 15, 2009 Four advanced pieces of scientific laboratory equipment with a total value of approximately $1 million now are available for use by University of Wisconsin-Madison stem cell and other researchers at several campus departments and centers due to a donation by the private nonprofit WiCell Research Institute.
• Wisconsin team grows retina cells from skin-derived stem cells Aug. 24, 2009 A team of scientists from the University of Wisconsin-Madison School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells - suggesting a future in which damaged retinas could be repaired by cells grown from the patient's own skin.
• Scientists make multiple types of white blood cells directly from embryonic and adult stem cells Aug. 11, 2009 In an advance that could help transform embryonic stem cells into a multipurpose medical tool, scientists at the University of Wisconsin-Madison have transformed these versatile cells into progenitors of white blood cells and into six types of mature white blood and immune cells.
• First cGMP feeder-independent pluripotent stem cell banks released for distribution July 6, 2009 The WiCell Research Institute and the Waisman Clinical Biomanufacturing Facility (WCBF) announced today (July 6) the release of the first current Good Manufacturing Practices (cGMP) feeder-independent pluripotent stem cell banks available for sale and distribution to researchers worldwide.
• WARF signs license agreement with Pfizer for human embryonic stem cells May 6, 2009 Pfizer Inc., a major biopharmaceutical company, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced May 5 that they have signed a license for human embryonic stem (hES) cell patents for the development of new drug therapies.
• Wisconsin, Morgridge scientists excise vector, exotic genes from induced stem cells March 26, 2009 A team of scientists from the Morgridge Institute for Research at the University of Wisconsin-Madison reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.